Female Sexual Dysfunction – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Female Sexual Dysfunction – Drugs In Development, 2024 report and make more profitable business decisions.
Female sexual dysfunction occurs when a woman is not able to fully, healthily, and pleasurably experience some or all of the various physical stages the body normally experiences during sexual activity. The predisposing factors include depression or anxiety, heart and blood vessel disease, liver or kidney failure, and certain medications, such as antidepressants or high blood pressure medications. Treatment includes estrogen therapy.
The Female Sexual Dysfunction drugs in development market research report provide comprehensive information on the therapeutics under development for Female Sexual Dysfunction, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Female Sexual Dysfunction and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Female Sexual Dysfunction | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 23 molecules, with 23 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Female Sexual Dysfunction therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Female Sexual Dysfunction pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Female Sexual Dysfunction treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Biozeus Pharmaceutical SACallitas Therapeutics Inc
Cosette Pharmaceuticals Inc
Dare Bioscience Inc
Freya Pharma Solutions BV
Initiator Pharma AS
Kuhnil Pharmaceutical Co Ltd
Lennham Pharmaceuticals Inc
Mithra Pharmaceuticals SA
Oncotelic Therapeutics Inc
Palatin Technologies Inc
S1 Biopharma Inc
Safety Shot Inc
Shanghai Fosun Pharmaceutical (Group) Co Ltd
TherapeuticsMD Inc
Thomas Advanced Medical LLC
Viramal Ltd
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Female Sexual Dysfunction reports